These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 20219600)

  • 1. Immunohistochemical expression of E-cadherin and beta-catenin in ameloblastomas and tooth germs.
    Alves Pereira KM; do Amaral BA; dos Santos BR; Galvão HC; Freitas Rde A; de Souza LB
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar; 109(3):425-31. PubMed ID: 20219600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoexpression of integrins in ameloblastoma, adenomatoid odontogenic tumor, and human tooth germs.
    de Souza Andrade ES; Miguel MC; de Almeida Freitas R; Pereira Pinto L; Batista de Souza L
    Int J Surg Pathol; 2008 Jul; 16(3):277-85. PubMed ID: 18573784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical detection of beta-catenin and adenomatous polyposis coli in ameloblastomas.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 2005 Aug; 34(7):401-6. PubMed ID: 16011608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical detection of insulin-like growth factors, platelet-derived growth factor, and their receptors in ameloblastic tumors.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 2007 Apr; 36(4):198-206. PubMed ID: 17391297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of tumor necrosis factor alpha, TNF-related apoptosis-inducing ligand, and their associated molecules in ameloblastomas.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 2005 May; 34(5):287-94. PubMed ID: 15817072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical detection of phosphorylated JNK, p38 MAPK, and ERK5 in ameloblastic tumors.
    Kumamoto H; Ooya K
    J Oral Pathol Med; 2007 Oct; 36(9):543-9. PubMed ID: 17850438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of E-cadherin and cytoplasmic-nuclear expression of beta-catenin are the most useful immunoprofiles in the diagnosis of solid-pseudopapillary neoplasm of the pancreas.
    Kim MJ; Jang SJ; Yu E
    Hum Pathol; 2008 Feb; 39(2):251-8. PubMed ID: 17959228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex correlates with the macroscopic appearance of early gastric cancer.
    Ohene-Abuakwa Y; Noda M; Perenyi M; Kobayashi N; Kashima K; Hattori T; Pignatelli M
    J Pathol; 2000 Dec; 192(4):433-9. PubMed ID: 11113859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of hMLH1 and hMSH2 proteins in ameloblastomas and tooth germs.
    Bologna-Molina R; Pereira-Prado V; Sánchez-Romero C; Tapia-Repetto G; Soria S; Hernandez M; Gónzalez-Gónzalez R; Molina-Frechero M; Mikami T
    Med Oral Patol Oral Cir Bucal; 2018 Mar; 23(2):e126-e131. PubMed ID: 29476681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical expression of beta-catenin, E-cadherin, cyclin D1 and c-myc in benign trichogenic tumors.
    Demirkan NC; Bir F; Erdem O; Düzcan E
    J Cutan Pathol; 2007 Jun; 34(6):467-73. PubMed ID: 17518774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation among expression of E-cadherin, beta-catenin, and cyclin D1 in breast cancers].
    Yang JF; Chen SL; Liu ZH; Zhang Y
    Ai Zheng; 2004 Jul; 23(7):799-802. PubMed ID: 15248915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal distribution of E-cadherin and beta-catenin in different histologic types of cancer of the uterine cervix.
    Rodríguez-Sastre MA; González-Maya L; Delgado R; Lizano M; Tsubaki G; Mohar A; García-Carrancá A
    Gynecol Oncol; 2005 May; 97(2):330-6. PubMed ID: 15863126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent occurrence of abnormal E-cadherin/beta-catenin protein expression in advanced gallbladder cancers and its association with decreased apoptosis.
    Hirata K; Ajiki T; Okazaki T; Horiuchi H; Fujita T; Kuroda Y
    Oncology; 2006; 71(1-2):102-10. PubMed ID: 17341890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal expression of E-cadherin and beta-catenin may be a molecular marker of submucosal invasion and lymph node metastasis in early gastric cancer.
    Tanaka M; Kitajima Y; Edakuni G; Sato S; Miyazaki K
    Br J Surg; 2002 Feb; 89(2):236-44. PubMed ID: 11856141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 gene status and expression of p53, MDM2, and p14 proteins in ameloblastomas.
    Kumamoto H; Izutsu T; Ohki K; Takahashi N; Ooya K
    J Oral Pathol Med; 2004 May; 33(5):292-9. PubMed ID: 15078490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E-cadherin and alpha-, beta-, and gamma-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions.
    Davidson B; Berner A; Nesland JM; Risberg B; Berner HS; Tropè CG; Kristensen GB; Bryne M; Ann Florenes V
    J Pathol; 2000 Dec; 192(4):460-9. PubMed ID: 11113863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E-cadherin and beta-catenin reduction influence invasion but not proliferation and survival in canine malignant mammary tumors.
    Brunetti B; Sarli G; Preziosi R; Monari I; Benazzi C
    Vet Pathol; 2005 Nov; 42(6):781-7. PubMed ID: 16301574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An immunohistochemical examination of the expression of E-cadherin, alpha- and beta/gamma-catenins, and alpha2- and beta1-integrins in invasive breast cancer.
    Gonzalez MA; Pinder SE; Wencyk PM; Bell JA; Elston CW; Nicholson RI; Robertson JF; Blamey RW; Ellis IO
    J Pathol; 1999 Apr; 187(5):523-9. PubMed ID: 10398116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of membrane localization and aberrant nuclear E-cadherin expression correlates with invasion in pancreatic endocrine tumors.
    Chetty R; Serra S; Asa SL
    Am J Surg Pathol; 2008 Mar; 32(3):413-9. PubMed ID: 18300809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value of E-cadherin, alpha-, beta-, and gamma-catenin in urothelial cancer of the upper urinary tract.
    Kashibuchi K; Tomita K; Schalken JA; Kume H; Yamaguchi T; Muto S; Horie S; Kitamura T
    Eur Urol; 2006 May; 49(5):839-45; discussion 845. PubMed ID: 16426728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.